Daniel O Obaseki1, Gregory E Erhabor1, Olayemi F Awopeju1, Olufemi O Adewole1, Bamidele O Adeniyi2, Emerita A Sonia Buist3, Peter G Burney4. 1. 1 Department of Medicine, Obafemi Awolowo University, Ile-Ife, Nigeria. 2. 2 Department of Medicine, Federal Medical Centre, Owo, Nigeria. 3. 3 Division of Pulmonary and Critical Care Medicine, Oregon Health & Science University, Portland, Oregon; and. 4. 4 Respiratory Epidemiology and Public Health, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
Abstract
RATIONALE: Black Africans have reduced FVC compared with white persons, but the prevalence and determinants of reduced values are not well understood. OBJECTIVES: To evaluate the prevalence and factors leading to reduced FVC in a Nigerian population and to examine current theories regarding the determinants of this difference. METHODS: We studied the ventilatory function of 883 adults aged 40 years or older participating in the Burden of Obstructive Lung Disease Study in Ile-Ife, Nigeria. Respondents completed pre- and post-bronchodilator spirometry test and provided information on their smoking history, respiratory symptoms, risk factors, and diagnoses, including anthropometric details. We used standard categories to define body mass index as either underweight, normal, overweight, or obese. We defined reduced FVC as a post-bronchodilator FVC below the lower limit of normal using National Health and Nutrition Examination Survey (NHANES) equations, Global Lung Function Initiative 2012 equations, and local reference equations based on nonsmoking study participants without a respiratory diagnosis. We fit multivariate linear regression models to FVC as a continuous measure, adjusting for age, sex, height, and other confounders. RESULTS: The prevalence of reduced FVC was 70.4% for men and 72.8% for women when using NHANES values for white Americans, 17.8% for men and 14.4% for women using NHANES equations for African Americans, and 15.5% for men and 20.5% for women using the Global Lung Function Initiative 2012 equations. Using the equations derived from nonsmoking respondents in the survey without a respiratory diagnosis, the prevalence of reduced FVC was less than 4% for both men and women. FVC was lower in participants who had less than 7 years of education (FVC, -96 ml; 95% confidence interval [CI], -172 to -19), were underweight (FVC, -269 ml; 95% CI, -464 to -73), were overweight (FVC, -132 ml; 95% CI, -219 to -46), and were obese (FVC, -222 ml; 95% CI, -332 to -112). CONCLUSIONS: There is a wide variation in the prevalence of reduced FVC based on the reference standard used. This variation is not satisfactorily explained by factors thought to affect FVC within individual populations. However, the prevalence strongly associates with both education level and body mass index in this population, regardless of the specific standard used.
RATIONALE: Black Africans have reduced FVC compared with white persons, but the prevalence and determinants of reduced values are not well understood. OBJECTIVES: To evaluate the prevalence and factors leading to reduced FVC in a Nigerian population and to examine current theories regarding the determinants of this difference. METHODS: We studied the ventilatory function of 883 adults aged 40 years or older participating in the Burden of Obstructive Lung Disease Study in Ile-Ife, Nigeria. Respondents completed pre- and post-bronchodilator spirometry test and provided information on their smoking history, respiratory symptoms, risk factors, and diagnoses, including anthropometric details. We used standard categories to define body mass index as either underweight, normal, overweight, or obese. We defined reduced FVC as a post-bronchodilator FVC below the lower limit of normal using National Health and Nutrition Examination Survey (NHANES) equations, Global Lung Function Initiative 2012 equations, and local reference equations based on nonsmoking study participants without a respiratory diagnosis. We fit multivariate linear regression models to FVC as a continuous measure, adjusting for age, sex, height, and other confounders. RESULTS: The prevalence of reduced FVC was 70.4% for men and 72.8% for women when using NHANES values for white Americans, 17.8% for men and 14.4% for women using NHANES equations for African Americans, and 15.5% for men and 20.5% for women using the Global Lung Function Initiative 2012 equations. Using the equations derived from nonsmoking respondents in the survey without a respiratory diagnosis, the prevalence of reduced FVC was less than 4% for both men and women. FVC was lower in participants who had less than 7 years of education (FVC, -96 ml; 95% confidence interval [CI], -172 to -19), were underweight (FVC, -269 ml; 95% CI, -464 to -73), were overweight (FVC, -132 ml; 95% CI, -219 to -46), and were obese (FVC, -222 ml; 95% CI, -332 to -112). CONCLUSIONS: There is a wide variation in the prevalence of reduced FVC based on the reference standard used. This variation is not satisfactorily explained by factors thought to affect FVC within individual populations. However, the prevalence strongly associates with both education level and body mass index in this population, regardless of the specific standard used.
Authors: A Sonia Buist; William M Vollmer; Sean D Sullivan; Kevin B Weiss; Todd A Lee; Ana M B Menezes; Robert O Crapo; Robert L Jensen; Peter G J Burney Journal: COPD Date: 2005-06 Impact factor: 2.409
Authors: Jamilah Meghji; Gilbert Nadeau; Kourtney J Davis; Duolao Wang; Moffat J Nyirenda; Stephen B Gordon; Kevin Mortimer Journal: Am J Respir Crit Care Med Date: 2016-07-01 Impact factor: 21.405
Authors: Peter Burney; Anamika Jithoo; Bernet Kato; Christer Janson; David Mannino; Ewa Nizankowska-Mogilnicka; Michael Studnicka; Wan Tan; Eric Bateman; Ali Koçabas; William M Vollmer; Thorarrin Gislason; Guy Marks; Parvaiz A Koul; Imed Harrabi; Louisa Gnatiuc; Sonia Buist Journal: Thorax Date: 2013-12-18 Impact factor: 9.139
Authors: D Obaseki; J Potts; G Joos; J Baelum; T Haahtela; M Ahlström; P Matricardi; U Kramer; M Gjomarkaj; W Fokkens; J Makowska; A Todo-Bom; K Toren; C Janson; S-E Dahlen; B Forsberg; D Jarvis; P Howarth; G Brozek; J Minov; C Bachert; P Burney Journal: Allergy Date: 2014-07-19 Impact factor: 13.146
Authors: Bharat Thyagarajan; David R Jacobs; George G Apostol; Lewis J Smith; Robert L Jensen; Robert O Crapo; R Graham Barr; Cora E Lewis; O Dale Williams Journal: Respir Res Date: 2008-04-04
Authors: Sarah Rylance; Chris Jewell; Andrew Naunje; Frank Mbalume; John D Chetwood; Rebecca Nightingale; Lindsay Zurba; Graham Flitz; Stephen B Gordon; Maia Lesosky; John R Balmes; Kevin Mortimer Journal: Thorax Date: 2020-02-20 Impact factor: 9.139
Authors: Sarah Rylance; Rebecca Nightingale; Andrew Naunje; Frank Mbalume; Chris Jewell; John R Balmes; Jonathan Grigg; Kevin Mortimer Journal: Thorax Date: 2019-08-29 Impact factor: 9.102
Authors: Martin W Njoroge; Sarah Rylance; Rebecca Nightingale; Stephen Gordon; Kevin Mortimer; Peter Burney; Jamie Rylance; Angela Obasi; Louis Niessen; Graham Devereux Journal: PLoS One Date: 2020-11-12 Impact factor: 3.240
Authors: Obianuju B Ozoh; Joy N Eze; Olufunke O Adeyeye; Ojiebun Eromosele; Sandra K Dede; Chizalu I Ndukwu; Richard Van Zyl-Smit Journal: Niger Med J Date: 2020-08-04
Authors: Chizalu Ifeyinwa Ndukwu; Obianuju B Ozoh; Boni Maxime Ale; Adaeze C Ayuk; Jacinta C Elo-Ilo; Babatunde I Awokola Journal: Clin Med Insights Pediatr Date: 2021-03-19
Authors: Nirav R Bhakta; David A Kaminsky; Christian Bime; Neeta Thakur; Graham L Hall; Meredith C McCormack; Sanja Stanojevic Journal: Chest Date: 2021-08-24 Impact factor: 9.410
Authors: Joy Nkiru Eze; Obianuju Beatrice Ozoh; Fred Chibuisi Otuu; Elvis Neba Shu; Bond Ugochukwu Anyaehie Journal: BMC Pulm Med Date: 2022-03-14 Impact factor: 3.317
Authors: K Mortimer; M Montes de Oca; S Salvi; K Balakrishnan; R M Hadfield; A Ramirez-Venegas; D M G Halpin; B Ozoh Obianuju; K Han MeiLan; R Perez Padilla; B Kirenga; J R Balmes Journal: Int J Tuberc Lung Dis Date: 2022-03-01 Impact factor: 3.427
Authors: Dorothy F L Sze; Timothy P Howarth; Clair D Lake; Helmi Ben Saad; Subash S Heraganahally Journal: Int J Chron Obstruct Pulmon Dis Date: 2022-04-21
Authors: Obianuju B Ozoh; Olufunto O Kalejaiye; Ojiebun E Eromesele; Yusuf A Adelabu; Sandra K Dede; Folasade O Ogunlesi Journal: Ann Thorac Med Date: 2019 Oct-Dec Impact factor: 2.219